SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-024195
Filing Date
2022-11-10
Accepted
2022-11-10 08:31:19
Documents
62
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q gmtx-20220930.htm   iXBRL 10-Q 2369757
2 EX-31.1 gmtx-ex31_1.htm EX-31.1 18562
3 EX-31.2 gmtx-ex31_2.htm EX-31.2 18522
4 EX-32.1 gmtx-ex32_1.htm EX-32.1 28225
  Complete submission text file 0000950170-22-024195.txt   6865326

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gmtx-20220930_pre.xml EX-101.PRE 276447
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gmtx-20220930_lab.xml EX-101.LAB 394845
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gmtx-20220930_def.xml EX-101.DEF 160338
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gmtx-20220930_cal.xml EX-101.CAL 29145
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gmtx-20220930.xsd EX-101.SCH 54874
56 EXTRACTED XBRL INSTANCE DOCUMENT gmtx-20220930_htm.xml XML 929120
Mailing Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139
Business Address 300 ONE KENDALL SQUARE, 3RD FLOOR CAMBRIDGE MA 02139 (617) 401-4400
Gemini Therapeutics, Inc. /DE (Filer) CIK: 0001816736 (see all company filings)

IRS No.: 851613057 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39438 | Film No.: 221375120
SIC: 2834 Pharmaceutical Preparations